目的采用6-羟基多巴胺(6-OHDA)部分损伤大鼠帕金森病模型,探讨尼古丁保护多巴胺能神经元的机制。方法雌性SD大鼠60只采用随机数字表法分为三组:尼古丁高剂量治疗组(尼古丁2.0mg/kg腹膜腔内注射1、低剂量治疗组(尼古丁0.2mg/kg腹膜腔内注射1及模型对照组(生理盐水腹膜腔内注射1,每组20只。注射7d后,分别接受单侧纹状体内6-OHDA20μg注射,制作帕金森病模型。免疫组织化学及体视学方法定量分析黑质多巴胺能神经元和纹状体CD3、CD4和CD8阳性淋巴细胞数量。结果6-OHDA注射4周后,模型对照组注射侧黑质酪氨酸羟化酶(TH)免疫阳性细胞为对照侧的25.27%;而在尼古丁低剂量和高剂量组,注射侧的TH免疫阳性细胞分别为相应对照侧的64.97%和67.24%。各组各时间点6-OHDA注射侧纹状体有明显的T淋巴细胞浸润。尼古丁治疗组浸润的T淋巴细胞数较模型对照组明显减少,差异有统计学意义(P〈0.051,而CD4和CD8阳性细胞占总T淋巴细胞的比例在各组和各时间点基本一致。尼古丁治疗组和模型对照组比较差异无统计学意义(P〉0.051。结论尼古丁可抑制6-OHDA损伤诱导的T淋巴细胞浸润,对抗6-OHDA神经细胞毒性,保护多巴胺能神经元。
Objective To explore the mechanism through which nicotine protects dopaminergic neurons against 6-hydroxydopamine (6-OHDA) toxicity in Parkinson's disease (PD) rat model. Methods Sixty Female SD rats were divided into 3 groups according to randomly digital table: High dosage group (nicotine 2 mg/kg, 5 injections i.p. per day at 2-h interval), low dosage group (nicotine 0.2 mg/kg, 5 injections i.p. per day at 2-h interval) and model group (normal saline treatment), n=20 each group. On day 8 after the treatment, a single injection of 20 μg of 6-OHDA was administered into striatum. Nicotine or normal saline was administered continuously daily until animals were killed. The dopaminergic neurons and CD3, CD4 and CD8-positive lymphocytes were analyzed quantitatively using immunohistochemistry and stereology. Results Four weeks after 6-OHDA administration, in the normal saline treated group, tyrosine hydroxylase-immunopositive cells in the substantia nigra of administered side was 25.27% of those in the one of non-administered side, and the immunopositive cells in 0.2 and 2 mg/kg nicotine treated groups were respectively 64.97% and 67.24% of those in the non-administered side. The loss of dopaminergic neurons induced by 6-OHDA in the substantia nigra was significantly less severe in the nicotine treatment groups (at both 0.2 and 2 mg/kg groups) than the saline treated group. T lymphocyte infiltration was markedly induced by 6-OHDA administration into striatum in all groups. In the striatum, we observed that the numbers ofCD3, CD4 and CD8-positive lymphocytes were reduced significantly in the nicotine treated animals as compared to saline controls (P〈0.05). The proportions of CD4 and CD8 positive cells in the total T lymphocytes were roughly equivalent in all groups at all time points, and there were no significant difference between nicotine treated groups and saline treated group. Conclusion Nicotine may have a neuroprotective effect against 6-OHDA induced dooaminergic lesion by inhib